Determination and characterization of candida species in people living with hiv/aids who attend an urban hospital clinic
DOI:
https://doi.org/10.54495/Rev.Cientifica.v18i1.168Keywords:
candida species, HIV/AIDS, urban hospital clinicAbstract
Candida is currently recognized as an opportunistic pathogen associated with episodes of recurrent oral candidiasis in people living with HIV/AIDS (PLWHA). There are more than 150 species of Candida, of which 10 are considered important pathogens for humans, the main species isolated in oral candidiasis being: C. albicans, C. glabrata, C. tropical and C. parapsilosis. The present study was carried out with the objective of determining and characterizing the presence of the different Candida species in oral infections of PLWHA who attended the "Luis Ángel García" Family Clinic of the San Juan de Dios General Hospital.
Downloads
References
Sanchez LO, et al. Point Prevalence, Microbiology and Antifungal Susceptibility Patterns of Oral Candida Isolates Colonizing or Infecting Mexican HIV/AIDS Patients and Healthy Persons. Rev Iberoam Micol 2005; 22: 83-92.
Pfaller MA, et al. International Surveillance of Bloodstream Infections due to Candida Species: Frecuency of Ocurrence and Antifungal Susceptibilities of Isolates Collected in 1997 in the United States, Canada and South America for the SENTRY Program, J Clin Microbiol 1998: 36: 1886-1889, https://doi.org/10.1128/JCM.36.7.1886-1889.1998 DOI: https://doi.org/10.1128/JCM.36.7.1886-1889.1998
Ellepola ANB, et al. Rapid and Unequivocal Differentiation of Candida dubliniensis from other Candida Species Using Species-specific DNA Probes: Comparison with Phenotypic Identification Methods. Oral Microbiol Immunol 2003; 18: 379-388, https://doi.org/10.1046/j.0902-0055.2003.00103.x DOI: https://doi.org/10.1046/j.0902-0055.2003.00103.x
Sullivan D, Coleman D. Candida dubliniensis: Characteristics and Identification. J Clin Microbiol 1998; 36(2): 329-334, https://doi.org/10.1128/JCM.36.2.329-334.1998 DOI: https://doi.org/10.1128/JCM.36.2.329-334.1998
Coleman D, et al. Candidiasis: The Emergence of a Novel Species, Candida dubliniensis. Official J Internal Aids Society 1997; 11(5): 557-567, https://doi.org/10.1097/00002030-199705000-00002 DOI: https://doi.org/10.1097/00002030-199705000-00002
Ramage G, Biofilm Formation of Candida dubliniensis. J Clin Microbiol 2001; 39(9): 3234-3240, https://doi.org/10.1128/JCM.39.9.3234-3240.2001 DOI: https://doi.org/10.1128/JCM.39.9.3234-3240.2001
Mosca C, et al. Casein Agar; a Useful Medium for Differentiating Candida dubliniensis from Candida albicans. J Clin Microbiol 2002 :41(3): 1259, https://doi.org/10.1128/JCM.41.3.1259-1262.2003 DOI: https://doi.org/10.1128/JCM.41.3.1259-1262.2003
Kirkpatrick W, et al. Detection of Candida dubliniensis Oropharyngeal Samples from Human Immunodeficiency Virus-Infected Patients in North America by Primary CHROMagar Candida Screening and Susceptibility Testing of Isolates. J Clin Microbiol 1998; 36(10): 3007-3012, https://doi.org/10.1128/JCM.36.10.3007-3012.1998 DOI: https://doi.org/10.1128/JCM.36.10.3007-3012.1998
Henry J, et al. El Laboratorio en el Di agnóstico Clínico. España: Editorial Marbán Libros, Tomo 2, 2005. 1504p. (p. 1172-1173).
Gutierrez J, et al. Evaluation of the ATB 32 C, Automicrobic System and API 20 C Using Clinical Yeast Isolates. Ann Biol Clin 1994; 50:443-446.
Fothergill AW, Rinaldi M G . Comparative Evaluation of Macrodilution and Alamar Colorimetric for Antifungal Susceptibility Testing of Yeast Isolates. J Clin Microbiol 1995; 33: 2660-2664, https://doi.org/10.1128/jcm.33.10.2660-2664.1995 DOI: https://doi.org/10.1128/jcm.33.10.2660-2664.1995
Patel M, et al. Effect of Antifungal Treatment on the Prevalence of Yeasts in HIV-Infected Subjects. J Med Microbiol 2006: 55: 1279-1284, https://doi.org/10.1099/jmm.0.46588-0 DOI: https://doi.org/10.1099/jmm.0.46588-0
Samaranayake LP, et al. Oral Candidiasis and Human Immunodeficiency Virus Infection. J Oral Pathol Med 1989; 18: 554-564, https://doi.org/10.1111/j.1600-0714.1989.tb01552.x DOI: https://doi.org/10.1111/j.1600-0714.1989.tb01552.x
Syrjanen S , et al. Oral Candida Infection as Sign of HIV Infection in Homosexual Men. Oral Surg Oral Med Oral Pathol 1988: 65: 36-40, https://doi.org/10.1016/0030-4220(88)90188-0 DOI: https://doi.org/10.1016/0030-4220(88)90188-0
Oliver M, et a I. Serotiposde Candida albicans Aislados en Pacientes VIH Positivos. Rev Iberoam Micol 1999; 16: 204-207.
Reznik D D S , David A. Perspective: Oral Manifestations of HIV Disease. IAS-USA 2005; 13(5): 143-148.
Samayoa B, Arathoon E, et al. The Emergente of AIDS in Guatemala: Impatient Experience at the Hospital General San Juan de Dios. International J STD & AIDS 2003; 14: 810-813, https://doi.org/10.1258/095646203322556138 DOI: https://doi.org/10.1258/095646203322556138
Richardson MD , Warnock DW . Fungal Infection: Diagnosis and Management. London: Blackwell Scientific Publications, 1993.
Flores Z . et al . Candidiasis Esofágica en Pacientes con SIDA. Estudio Clínico y Microbiológico. Rev Cubana Med Trop 1997; 50(2): 110-114.
Goltfredsson M , et al. Association of Plasma Levels of Human Immunodeficiency Virus Type 1 RNA and Oropharyngeal Candida Colonization. J Infect Dis 1999; 180: 534-537, https://doi.org/10.1086/314887 DOI: https://doi.org/10.1086/314887
Fernández R. Mandel S. Micosis Profundas en Pacientes con SIDA. Rev Soc Ven Microbiol 1990; 17.
Salazar A. et al. Guía de Tratamiento Antirretroviral y de Infecciones Oportunistas en Guatemala. Progr Nac ITS, VIH y SIDA. Guatemala: Ministerio de Salud Pública, 2006.
Moran G. etal. Antifungal Drug Susceptibilities of Oral Candida dubliniensis Isolates from Human Inmunodeficiency Virus (HIV)- Infected and Non-HIV-Infected Subjects and Generation of Stable Fluconazole-Resistant Derivatives in Vitro. Anti Agents Chemo 1997: 41(3): 617-623, https://doi.org/10.1128/AAC.41.3.617 DOI: https://doi.org/10.1128/AAC.41.3.617
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2010 W. Paiz, S. Lima, E. Arathoon, B. Samayoa
This work is licensed under a Creative Commons Attribution 4.0 International License.
Los autores/as que publiquen en esta revista aceptan las siguientes condiciones:
- Los autores/as conservan los derechos de autor y ceden a la revista el derecho de la primera publicación, con el trabajo registrado con la licencia de atribución de Creative Commons 4.0, que permite a terceros utilizar lo publicado siempre que mencionen la autoría del trabajo y a la primera publicación en esta revista.
- Los autores/as pueden realizar otros acuerdos contractuales independientes y adicionales para la distribución no exclusiva de la versión del artículo publicado en esta revista (p. ej., incluirlo en un repositorio institucional o publicarlo en un libro) siempre que indiquen claramente que el trabajo se publicó por primera vez en esta revista.
- Se permite y recomienda a los autores/as a compartir su trabajo en línea (por ejemplo: en repositorios institucionales o páginas web personales) antes y durante el proceso de envío del manuscrito, ya que puede conducir a intercambios productivos, a una mayor y más rápida citación del trabajo publicado.
